Platelet-rich plasma for bone graft enhancement in sinus floor augmentation with simultaneous implant placement: Patient series study

Implant Dentistry

Volumn 13, Issue 1, 2004, Pages 65-72

  Mazor, Ziv ^a   Peleg, Michael ^b   Garg, Arun K ^b,d   Luboshitz, Jacob ^c  

^a Periodontoiogy   (Israel)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

^d NONE   (United States)

Author keywords

Bone augmentation; Dental implants; Growth factors; Platelet rich plasma

Indexed keywords

METAL; THROMBIN; ALLOY; COAGULATING AGENT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE GRAFT; BONE MATURATION; COMPOSITE MATERIAL; HEALING; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MAXILLA; OSTEOLYSIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSTHESIS; RADIOGRAPHY; SOFT TISSUE; THROMBOCYTE RICH PLASMA; TOOTH IMPLANTATION; XENOGRAFT; BONE PROSTHESIS; BONE REGENERATION; BONE TRANSPLANTATION; FOLLOW UP; MAXILLARY SINUS; METHODOLOGY; MIDDLE AGED; ORAL SURGERY; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE TRANSFUSION; TOOTH PROSTHESIS;

ADULT; AGED; ALVEOLAR RIDGE AUGMENTATION; BLOOD PLATELETS; BONE SUBSTITUTES; BONE TRANSPLANTATION; COAGULANTS; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DENTAL PROSTHESIS, IMPLANT-SUPPORTED; FOLLOW-UP STUDIES; HUMANS; MAXILLA; MAXILLARY SINUS; METAL CERAMIC ALLOYS; MIDDLE AGED; OSSEOINTEGRATION; PLATELET TRANSFUSION; THROMBIN;

EID: 2342655816     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ID.0000116454.97671.40     Document Type: Article

References (32)

1. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma. Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638-646.
2. Cramer EM. Platelet and megakaryocytes: Anatomy and structural organization. In: Colman RW, Hirsh J, Marder VJ, et. al., eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 3rd ed. Philadelphia: JB Lippincott; 2001:411-428.
3. King GL, Buchwald S. Characterization and partial purification of an endothelial cell growth factor from human platelets. J Clin Invest. 1984;73:392-396.
4. Devine DV, Bishop PD. Platelet-associated factor XIII in platelet activation, adhesion and clot stabilization. Semin Thromb Hemost. 1996;22:409-413.
5. Hsieh SC, Graves TD. Pulse application of platelet-derived growth factor enhances formation of a mineralizing matrix while continuous application is inhibitory. J Cell Biochem. 1998;69:169-180.
6. Ducy P, Schinke T, Karsenty G. The osteoblast: A sophisticated fibroblast under central surveillance. Science. 2000;289:1501-1504.
7. Cassiede P, Dennis JE, Ma F, et al. Osteochondrogenic potential of marrow mesenchymal progenitor cell exposed to TGF-beta 1 or PDGF-BB as assayed in vivo and in vitro. J Bone Miner. 1996;11:1264-1273.
8. Lind M. Growth factor stimulation of bone healing. Effect on osteoblasts, osteotomies, and implant fixation. Acta Orthop Scand Suppl 1998;Oct:2832-2837.
9. Maloney JP, Silliman CC, Ambruso DR, et al. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol. 1998;275:H1054-1061.
10. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001;49:507-521.
11. Pierce GF, Tarpley JE, Yanagihara D, et al. Platelet-derived growth factor (BB-homodimer), transforming growth factor-β1, and basic fibroblast growth factor in dermal wound healing. Am J Pathol. 1992;140:1375-1388.
12. Lynch SE, de Castilla GR, William RC, et al. The effects of short-term application of a recombination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol. 1991;62:458-467.
13. Ashby B, Colman RW, Daniel JL, et al. Platelet stimulatory and inhibitory receptors. In: Colman R, Hirsh J, Marder VJ, et al., eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 3rd ed. Philadelphia: JB Lippincott; 2001:505-520.
14. Chang MC, Chan CP, Wu HL, et al. Thrombin-stimulated growth, clustering, and collagen lattice contraction of human gingival fibroblast is associated with its protease activity. J Periodontol. 2001;72:303-313.
15. Frost A, Jonsson KB, Ridefelt P, et al. Thrombin, but not bradykinin, stimulates proliferation in isolated human osteoblasts, via prostaglandin formation. Acta Orthop Scand. 1999;70:497-503.
16. Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis. Potentiation of the vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptor. J Biol Chem. 1999;274:23969-23976.
17. Abraham LA, Mackie JM. Modulation of osteoblast-like cell behavior by activation of protease-activated receptor-1. J Bone Miner Res. 1999;14:1320-1329.
18. Jenny NS, Mann KG. Thrombin. In: Colman R, Hirsh J, Marder VJ, et al., eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 3rd ed. Philadelphia: JB Lippincott; 2001:171-189.
19. Blomback B, Carlsson K, Fatah K, et al. Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activation. Thromb Res. 1994;75:521-538.
20. IIbβ3 and platelet aggregation. In: Colman R, Hirsh J, Marder VJ, et al., eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 3rd ed. Philadelphia: JB Lippincott, 2001:479-491.
21. Anitua E. Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999;14:529-535.
22. Garg AK, Quinones CR. Augmentation of the maxillary sinus: A surgical technique. Pract Periodont Aesthet. 1997;9:211-219.
23. Froum SJ, Tarnow DP, Wallace SS, et al. Sinus floor elevation using an organic bovine bone matrix (OsteoGraf/N) with and without autogenous bone: A clinical, histologic, radiographic, and histomorphometric analysis-Part 2 of an ongoing prospective study. Int J Periodont Rest Dent. 1998;18:528-543.
24. Bhanot S, Alex JC. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg. 2000;18:27-33.
25. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (Becaplermin) in patients with chronic neuropathic diabetic ulcers. Diabetes Care. 1998;21:822-827.
26. Robson M, Phillips LG, Thomason A, et al. Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers. Ann Plast Surg. 1992;29:193-201.
27. Obarrio J, Arauz-Dutari J, Chamberlain T, et al. The use of autologous growth factors in periodontal surgical therapy: Platelet gel biotechnology - Case reports. Int J Periodont Rest Dent. 2000;20:486-497.
28. Man D, Posker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg. 2001;107:238-239.
29. Ortel TL, Charles LA, Keller FG, et al. Topical thrombin and acquired coagulation factor inhibitors: Clinical spectrum and laboratory diagnosis. Am J Hematol. 1994;45:128-135.
30. Zumberg MS, Waples JM, Kao KJ, et al. Management of a patient with mechanical aortic valve and antibodies to both thrombin and factor V after repeat exposure to fibrin sealant. Am J Hematol. 2000;64:59-63.
31. Foster PR, Welch AG, McLean C, et al. Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma product. Vox Sang. 2000;78:86-95.
32. Garg AK. Grafting materials in repair and restoration. In: Lynch SE, Genco R, Marx R, eds. Tissue Engineering: Applications in Maxillofacial Surgery and Periodontics. Chicago: Quintessence Publishing; 1998:83-101.